Transposon Therapeutics

Transposon Therapeutics, Inc

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical development

Model

01Company Overview

Transposon Therapeutics, Inc. is pioneering novel therapies targeting LINE-1 activity, including reverse transcriptase and other key mediators of LINE-1-induced pathology, with a focus on treating neurodegenerative diseases.

02Backed By1 investor

LVLumira Ventures→

03Similar Companies

AT

Is this your company? Claim your profile

Arclight Therapeutics

Biotech & Life Sciences

→

RT

reverSASP Therapeutics

Biotech & Life Sciences

→

VT

Vima Therapeutics

Biotech & Life Sciences

→

RL

Rejuveron Life Sciences

Biotech & Life Sciences

→

CT

Crucible Therapeutics

Biotech & Life Sciences

→

04Startup DNA

8

signals

Sectors
Business Model
Technology